| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/06/2002 | EP1177283A1 Regulation of viral gene expression |
| 02/06/2002 | EP1177277A2 Compositions and methods for the modification of gene transcription |
| 02/06/2002 | EP1177214A1 49 human secreted proteins |
| 02/06/2002 | EP1177211A2 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 02/06/2002 | EP1176995A1 A tissue engineering scaffold |
| 02/06/2002 | EP1176994A1 Biostability of polymeric structures |
| 02/06/2002 | EP1176993A1 Biostable polyurethane products |
| 02/06/2002 | EP1176986A1 Differentiation of monocytes into functional dendritic cells |
| 02/06/2002 | EP1176970A2 Xenotransplant for cns therapy |
| 02/06/2002 | EP0944716A4 Imidazolinone herbicide resistant sugar beet plants |
| 02/06/2002 | EP0941478B1 Assay method for peptide specific t-cells |
| 02/06/2002 | EP0789844B1 The use of a bmp protein receptor complex for screening bone metabolism actives and cells co-transfected with a type ii bmp receptor and a type i bmp receptor |
| 02/06/2002 | EP0672156B1 Bovine heat shock promoter and uses thereof |
| 02/06/2002 | CN1334923A Whole cell selection utilizing azlactone-functional supports |
| 02/06/2002 | CN1334878A Polynucleotide comprising ubiquitous chromatin opening element (UCDE) |
| 02/06/2002 | CN1334877A Co-expression of proteins |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334870A Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/06/2002 | CN1334866A Materials and methods for modification of isoprenoid content, composition and metabolism |
| 02/06/2002 | CN1334339A Technology for obtaining synchronized stem cells coming from same animal archeocyte |
| 02/05/2002 | USRE37543 Cloned by phenotype complementation of pseudomonas putida kt2440 mutants, defective in the polyhydroxyalkanoic acid (pha) synthesis via de novo fatty acid biosynthesis but not affected in pha biosynthesis via fatty acid b-oxidation |
| 02/05/2002 | US6344602 Method to obtain male sterile plants |
| 02/05/2002 | US6344601 Transforming plants with an actin binding protein and allowing expression of profilin, causing cell elongation in growing plants and resulr in plants having a tall phenotype |
| 02/05/2002 | US6344598 Producing a sterile plant seed by cross pollinating a plant which is seed forming and male sterile, having a foreign dna sequence; the stamen cells are killed by expression of male sterility dna, then herbicides eliminate male fertile plants |
| 02/05/2002 | US6344596 Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | US6344546 A receptor protein with a cytoplasmic domain having protein kinase activity, a kinase insert, a transmembrane domain and an extracellular domain having three immunoglobulin-like repeats; for drug screening |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome |
| 02/05/2002 | US6344541 DKR polypeptides |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344440 Antisecretory factor peptides regulating pathological permeability changes |
| 02/05/2002 | US6344322 Subtle mitochondrial mutations as tumor markers |
| 02/05/2002 | US6344192 Ex vivo cultivated t lymphocytes, treated with il-15 or active variants thereof, during the ex vivo cultivation procedure; stimulating formation and promoting survival of memory t cells which recognize a specific antigen in a mammal |
| 02/05/2002 | CA2150714C Syndecan stimulation of cellular differentiation |
| 02/05/2002 | CA2006473C Improved anti-infective therapy |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/03/2002 | CA2340783A1 Ampk-related serine/threonine kinase, designated snark |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008751A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 01/31/2002 | WO2002008453A2 Canine toxicity genes |
| 01/31/2002 | WO2002008441A1 Process for producing non-cellulosic callose fiber by plant protoplast and callose fiber |
| 01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | WO2002008429A2 Vdup1 promoter and methods of use thereof |
| 01/31/2002 | WO2002008424A1 Human and rat abca2 genes |
| 01/31/2002 | WO2002008410A2 Nucleic acids compositions conferring dwarfing phenotype |
| 01/31/2002 | WO2002008409A2 Methods for the replacement, translocation and stacking of dna in eukaryotic genomes |
| 01/31/2002 | WO2002008401A2 Elongase genes and uses thereof |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008389A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | WO2002008388A2 Stem cell-like cells |
| 01/31/2002 | WO2002008387A1 Heart muscle-like cell sheet, three-dimensional construct, heart muscle-like tissue and process for producing the same |
| 01/31/2002 | WO2002008386A2 Materials and methods for the enhancement of effective root nodulation in legumes |
| 01/31/2002 | WO2002008383A2 Sp110, a polypeptide component of the nuclear body |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008290A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008269A2 A cytochrome p450 enzyme associated with the synthesis of δ12-epoxy groups in fatty acids of plants |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008264A2 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008254A1 Compositions and methods for cancer screening |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002007752A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 01/31/2002 | WO2002007748A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 01/31/2002 | WO2002007679A2 Adult human dental pulp stem cells in vitro and in vivo |
| 01/31/2002 | WO2002007646A2 Artificial vascular grafts, and methods of producing and using same |
| 01/31/2002 | WO2002007514A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | WO2001083562A3 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/31/2002 | WO2001082773A3 Structures useful for bone engineering and methods |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/31/2002 | WO2001049243A3 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 01/31/2002 | WO2001044482A3 Optimized t-dna transfer and vectors therefor |
| 01/31/2002 | WO2001044478A3 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
| 01/31/2002 | WO2001040473A3 Pseudomonas aeruginosa antigens |
| 01/31/2002 | WO2001038514A3 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams |
| 01/31/2002 | WO2001038503A3 Novel human protein kinases and protein kinase-like enzymes |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001034801A3 Recombinant gelatin in vaccines |
| 01/31/2002 | WO2001030992A3 α1-3 GALACTOSYLTRANSFERASE GENE AND PROMOTER |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000063410A9 Methods and compositions for transforming cells using site-specific recombination |